본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Journal of the American Geriatrics Society v.65 no.1, 2017년, pp.77 - 82   SCI SCIE SSCI
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus

Sarkar, Urmimala (Center for Vulnerable Populations, Division of General Internal Medicine, University of California San Francisco, San Francisco, California ) ; Lyles, Courtney (Center for Vulnerable Populations, Division of General Internal Medicine, University of California San Francisco, San Francisco, California ) ; Steinman, Michael (Division of Geriatrics, University of California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California ) ; Huang, Elbert S. (School of Medicine, University of Chicago, Chicago, Illinois ) ; Moffet, Howard H. (Division of Research, Kaiser Permanente, Oakland, California ) ; Whitmer, Rachel A. (Division of Research, Kaiser Permanente, Oakland, California ) ; Warton, E. Margaret (Division of Research, Kaiser Permanente, Oakland, California ) ; Karter, Andrew J. (Division of Research, Kaiser Permanente, Oakland, California ) ;
  • 초록  

    Objectives To assess changes in medication use after a diagnosis of dementia in individuals with type 2 diabetes mellitus. Design Difference‐in‐differences analysis of changes in the number of dispensed chronic medications between individuals with and without newly diagnosed dementia. Setting Integrated healthcare delivery system, Kaiser Permanente Northern California. Participants Individuals aged 50 and older without prevalent dementia with type 2 diabetes mellitus enrolled in a baseline survey. During 5 years of follow‐up, 193 individuals with a new diagnosis of dementia were identified, and risk‐set sampling was used to randomly select five reference subjects per case matched on 5‐year age categories and sex (965 matched participants), resulting in an analytical sample of 1,158. Measurements The exposure was new diagnosis of dementia. The primary outcome was change in number of current chronic medications (total, cardiovascular (blood pressure and lipid control), diabetes mellitus) at three times: 1 year before index date (preindex date), date of diagnosis of dementia or matched reference date (index date), and up to 1 year after index date or end of follow‐up if censored before 1 year (postindex date). Results After adjustment, the number of chronic medications and the subset of cardiovascular medications declined after a dementia diagnosis in the overall cohort and in age‐, sex‐, and time‐matched reference individuals, but the decline was significantly greater in the group with dementia (0.71 medications fewer than the reference group, P = .02). The number of diabetes mellitus medications declined in both groups, but the declines were not statistically different (0.18 medications fewer than the reference group, P = .008). Conclusions Use of cardiometabolic medications fell after a diagnosis of dementia, as recommended in national guidelines.


  • 주제어

    polypharmacy .   dementia .   diabetes mellitus.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기